Sequence Similarity Clusters for the Entities in PDB 1NAM

Entity #1 | Chains: A
BM3.3 T Cell Receptor alpha-Chain protein, length: 116 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 33155
95 % 2 2 28623 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 2 2 27497
70 % 2 2 24756
50 % 2 2 21226
40 % 264 373 27
30 % 5270 7460 1
Entity #2 | Chains: B
BM3.3 T Cell Receptor beta-Chain protein, length: 113 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 29443
95 % 2 3 25721 Flexibility: Low
Max RMSD: 0.9, Avg RMSD: 0.8
PDBFlex
90 % 4 5 13565
70 % 4 5 12734
50 % 4 5 11303
40 % 4 5 10159
30 % 5271 7460 1
Entity #3 | Chains: H
H-2 class I histocompatibility antigen, K-B alpha chain precursor protein, length: 275 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 45 53 463
95 % 55 65 444 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.1
PDBFlex
90 % 59 70 410
70 % 674 757 6
50 % 685 771 7
40 % 721 823 9
30 % 807 950 13
Entity #4 | Chains: P
Nucleocapsid protein, length: 8 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
Entity #5 | Chains: L
Beta-2-microglobulin protein, length: 100 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 35 45 547
95 % 184 234 64 Flexibility: Low
Max RMSD: 1.8, Avg RMSD: 0.6
PDBFlex
90 % 184 234 70
70 % 829 965 4
50 % 843 987 3
40 % 843 987 6
30 % 843 987 9

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
34 6EH4 2 E Human T Cell Receptor Beta Chain 9606
35 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
36 4BUH 1 A, B CLONE M0418 SCFV 9606
37 4B50 1 A 2H10 LLAMA VHH 9844
38 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
39 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
40 6FR4 1 A TCR 003 alpha chain 9606
41 6FR4 2 B TCR 003 Beta Chain 9606
42 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
43 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
44 6DBA 1 A, B nanobody VHH R303 9838
45 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
46 6EH5 2 B Human T Cell Receptor Beta Chain 9606
47 5YD4 1 A, C, E, G scFv 4B08 10090
48 5YD3 1 A, C, E, G scFv 4B08 10090
49 2XT1 2 B CAMELID VHH 9 30538
50 5UD9 1 H Fab heavy chain 9606
51 5UD9 2 L Light chain 9606
52 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
53 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
54 4P48 1 A Antibody scFv 180 9031
55 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
56 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
57 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
58 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
59 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
60 6FR3 1 A 003 TCR Alpha Chain 9606
61 6FR3 2 B 003 TCR Beta Chain 9606
62 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
63 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
64 5J1S 3 C VHH domain BS-2 30538
65 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
66 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
67 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
68 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
69 5L6Q 1 A, B H5AL 9606
70 5J1T 3 C VHH domain BS-2 30538
71 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
72 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
73 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
74 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
75 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
76 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
77 4XCF 1 L 4E10 Fab light chain 9606
78 4XCF 2 H 4E10 Fab heavy chain 9606
79 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
80 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
81 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
82 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
83 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
84 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
85 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
86 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
87 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
88 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
89 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
90 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
91 5X08 1 H Fab 4E10 Heavy chain 9606
92 5X08 2 L Fab 4E10 Light chain 9606
93 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
94 2X1O 1 A, B GELSOLIN NANOBODY 9844
95 4QGY 1 A, B nanobody n25, VH domain 9844
96 5C2B 1 H scFv 3B4 heavy chain 9606
97 5C2B 2 L 3B4 light chain 9606
98 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
99 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
100 4XAW 1 L 4E10 Fab light chain 9606
101 4XAW 2 H 4E10 Fab heavy chain 9606
102 5VNV 1 A Nb.b201 32630
103 4P49 1 A Antibody scFv B8 9031
104 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
105 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
106 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
107 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
108 5DXW 1 A PD-L1 nanobody 10090
109 2NW2 1 A ELS4 TCR alpha chain 9606
110 2NW2 2 B ELS4 TCR beta chain 9606
111 5UCB 1 H Fab Heavy Chain 9606
112 5UCB 2 L Fab Light Chain 9606
113 3T0W 1 A, B immunoglobulin variable lambda domain 9606
114 2VXV 1 H HUMAN IGG ABT-325 9606
115 2VXV 2 L HUMAN IGG ABT-325 9606
116 4N9O 2 B Nanobody Nb484 Nb484 9844
117 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
118 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
119 3T0V 1 A immunoglobulin variable lambda domain 9606
120 4GXV 1 H, I Antibody 1F1, heavy chain 9606
121 4GXV 2 L, M Antibody 1F1, light chain 9606
122 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
123 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
124 2VXT 1 H MURINE IGG 125-2H 10090
125 2VXT 3 L MURINE IGG 125-2H 10090
126 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
127 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
128 1T2J 1 A M12-Variable Heavy domain 9606
129 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
130 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
131 6DBF 2 B InlB specific VHH R303 9838
132 6DBG 2 C, D VHH R303 9838
133 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
134 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
135 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
136 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
137 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
138 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
139 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
140 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
141 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
142 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
143 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
144 5W24 1 L 5C4 Fab Light Chain 10090
145 5W24 2 H 5C4 Fab Heavy Chain 10090
146 4HPY 1 H CH59 Fab heavy chain 9606
147 4HPY 2 L CH59 Fab light chain 9606
148 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
149 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
150 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
151 5VM6 1 A single domain camelid nanobody VHH T10 9844
152 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
153 4JG1 1 L Fab light chain 9606
154 4JG1 2 H Fab heavy chain 9606
155 1SQ2 2 N novel antigen receptor 7801
156 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
157 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
158 4KML 2 B Nanobody 9844
159 5VF2 1 A scFv 2D10 10090
160 5I8C 1 A VRC34.01 Fab heavy chain 9606
161 5I8C 2 B VRC34.01 Fab light chain 9606
162 4O5L 1 L Fab F045-092 light chain 9606
163 4O5L 2 H Fab F045-092 heavy chain 9606
164 5MYX 1 A, C Fab c#24 light chain 10090
165 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
166 4Z9K 2 B VHH2(F5) antibody 30538
167 3IFL 1 L 12A11 FAB antibody light chain 10090
168 3IFL 2 H 12A11 FAB antibody heavy chain 10090
169 5WK2 1 L M116 LIGHT CHAIN 9606
170 5WK2 2 H M116 HEAVY CHAIN FD 9606
171 3PP4 1 H GA101 Fab heavy chain 10090
172 3PP4 2 L GA101 Fab light chain 10090
173 3KDM 1 A, L Immunoglobulin light chain 9606
174 3KDM 2 B, H Immunoglobulin heavy chain 9606
175 5NIV 1 A Light chain of 5D3 Fab 10090
176 5NIV 2 B Heavy chain of 5D3 Fab 10090
177 5N4J 1 L LIGHT CHAIN 9606
178 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
179 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
180 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
181 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
182 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
183 5X4G 1 A 6H8 Fab heavy chain 10090
184 5X4G 2 B 6H8 Fab light chain 10090
185 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
186 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
187 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
188 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
189 4PTU 1 A Antibody pn132p2C05, light chain 9606
190 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
191 4TPR 1 L If kappa light chain 10090
192 4TPR 2 H Fab heavy chain 10090
193 5LMW 1 A Nanobody 9844
194 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
195 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
196 3IFN 1 H 12A11 FAB antibody heavy chain 10090
197 3IFN 2 L 12A11 FAB antibody light chain 10090
198 5U3P 1 H DH511.4 Fab Heavy Chain 9606
199 5U3P 2 L DH511.4 Fab Light Chain 9606
200 6BLA 1 H AMM01 Fab Heavy chain 9606
201 6BLA 2 L AMM01 Fab Light chain 9606
202 5NM0 1 A, B, C, D Nb36 9844
203 4TOY 1 H 35O22 Fab Heavy chain 9606
204 4TOY 2 L 35O22 Fab Light chain 9606
205 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
206 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
207 3NPS 2 B S4 FAB HEAVY CHAIN 9606
208 3NPS 3 C S4 FAB LIGHT CHAIN 9606
209 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
210 5I4F 1 A scFv 2D10 10090
211 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
212 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
213 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
214 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
215 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
216 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
217 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
218 5WN9 1 H scFv 2D10 9606
219 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
220 4XC3 1 L 4E10 Fab light chain 9606
221 4XC3 2 H 4E10 Fab heavy chain 9606
222 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
223 4PPT 1 A Engineered single domain VHH antibody 9844
224 3R0M 1 A, B Llama VHH A12 9844
225 4M5Y 1 H, I Fab 5J8 heavy chain 9606
226 4M5Y 2 L, M Fab 5J8 light chain 9606
227 4TQE 1 L If kappa light chain 10090
228 4TQE 2 H Fab heavy chain 10090
229 3ZKQ 2 D XA4813 9844
230 5YY4 1 A scFv 4B08 10090
231 4I13 2 B Protein ca1697 (nanobody) 9844
232 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
233 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
234 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
235 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
236 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
237 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
238 5C2U 1 B Nanobody Nanobody 9838
239 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
240 5VSI 2 L CH1/Ckappa Fab light chain 9606
241 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
242 1XFP 1 A heavy chain antibody VHH domain 9838
243 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
244 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
245 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
246 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
247 5JXA 1 H VRC03 Heavy chain 9606
248 5JXA 2 L VRC03 Light chain 9606
249 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
250 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
251 4POY 1 A VHH-metal 9844
252 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
253 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
254 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
255 5NLW 1 A nanobody Nb36 9844
256 3CDC 1 A, B Light Chain Amyloidogenic 9606
257 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
258 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
259 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
260 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
261 3NTC 1 L Fab light chain 10090
262 3NTC 2 H Fab heavy chain 10090
263 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
264 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
265 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
266 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
267 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
268 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
269 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
270 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
271 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
272 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
273 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
274 6BE3 1 H Fab (F598) Heavy Chain 9606
275 6BE3 2 L Fab (F598) Light Chain 9606
276 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
277 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
278 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
279 3G9A 2 B Minimizer 9838
280 4NWU 1 H APE1551 Ab Fab heavy chain 9606
281 4NWU 2 L APE1551 Ab Fab light chain 9606
282 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
283 1KGC 1 D T-cell receptor alpha chain 9606
284 1KGC 2 E T-cell receptor beta chain 9606
285 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
286 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
287 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
288 6FRC 2 B Human T-Cell Receptor beta Chain 9606
289 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
290 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
291 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
292 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
293 5EWI 1 H VRC38.01 Heavy Chain 9606
294 5EWI 2 L VRC38.01 Light Chain 9606
295 5E2W 1 L AT8 LIGHT CHAIN 10090
296 5E2W 2 H AT8 HEAVY CHAIN 10090
297 5MYK 1 A Fab c#17 light chain 10090
298 5MYK 2 B Fab c#17 heavy chain 10090
299 6FUQ 1 A Human F11 T-Cell Receptor 9606
300 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
301 4NZR 1 H PGT135 heavy chain Fab 9606
302 4NZR 2 L PGT135 light chain Fab 9606
303 5MYO 1 A, C Fab c#6 light chain 10090
304 5MYO 2 B, D Fab c#6 heavy chain 10090
305 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
306 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
307 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
308 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
309 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
310 5UEL 1 H 354NC102 Fab Heavy Chain 9606
311 5UEL 2 L 354NC102 Fab Light Chain 9606
312 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
313 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
314 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
315 2P43 2 B ANTIBODY CAB-RN05 9838
316 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
317 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
318 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
319 5E2V 1 L AT8 LIGHT CHAIN 10090
320 5E2V 2 H AT8 HEAVY CHAIN 10090
321 4KRN 1 A Nanobody/VHH domain EgA1 9844
322 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
323 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
324 4GFT 2 B Nanobody 9844
325 4TVS 2 a, b VHH Domain BS-1 30538
326 4W6Y 2 B Nanobody NbFedF9 9844
327 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
328 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
329 6EZW 1 B VHH antibody BCD090-M2 9844
330 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
331 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
332 5JUE 1 L light chain of UIC2 Fab 10090
333 5JUE 2 H heavy chain of UIC2 Fab 10090
334 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
335 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
336 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
337 1UAC 2 H Ig VH,anti-lysozyme 10090
338 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
339 5JR1 1 H 10E8 heavy chain 9606
340 5JR1 2 L 10E8 mature light chain 9606
341 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
342 6CA7 1 L PCT64_13C light chain 9606
343 6CA7 2 H PCT64_13C heavy chain 9606
344 5VF6 1 A single chain variable fragment 9031
345 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
346 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
347 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
348 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
349 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
350 6FR9 2 B T-Cell Receptor F11 beta chain 9606
351 5OB5 2 H fAb Heavy chain 9606
352 5OB5 3 L fAb Light chain 9606
353 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
354 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
355 5I66 1 A 8B6 antibody, heavy chain 10090
356 5I66 2 B 8B6 antibody, light chain 10090
357 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
358 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
359 6BZY 1 H 22D11 Heavy Chain 10090
360 6BZY 2 L 22D11 Light Chain 10090
361 3QQ9 1 C, L 101F LIGHT CHAIN 10090
362 3QQ9 2 D, H 101F HEAVY CHAIN 10090
363 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
364 5TKK 3 L mouse antibody vFP5.01 light chain 10090
365 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
366 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
367 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
368 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
369 5W6C 1 H UCA Fab heavy chain 9606
370 5W6C 2 L UCA Fab light chain 9606
371 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
372 5I1K 1 L FAB LIGHT CHAIN 9606
373 5I1K 2 H FAB HEAVY CHAIN 9606
374 3OZ9 1 L Fab NC-1 kappa light chain 10090
375 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
376 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
377 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
378 5V7U 1 L CBTAU-22.1 Fab light chain 9606
379 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
380 5UEA 1 A, H Fab Heavy Chain 9606
381 5UEA 3 B, L Fab Light Chain 9606
382 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
383 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
384 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
385 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
386 3G5Y 1 A 175 light chain 10090
387 3G5Y 2 B 175 heavy chain 10090
388 5O02 2 C Nanobody (VHH) Nano-4 30538
389 5NMV 1 L Fab light chain 10088
390 5NMV 2 H Fab heavy chain 10088
391 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
392 4N8C 2 L, M Light chain of monoclonal antibody 10090
393 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
394 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
395 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
396 4HGW 1 A Antibody Fab fragment, light chain 10090
397 4HGW 2 B Antibody Fab fragment, heavy chain 10090
398 1NLB 1 L antibody 19D9D6 light chain 10090
399 1NLB 2 H antibody 19D9D6 heavy chain 10090
400 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
401 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
402 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
403 3VFG 1 L 3F8 Light Chain 10090
404 3VFG 2 H 3F8 Heavy Chain 10090
405 4X7F 2 C, D Nano-25 Nanobody 30538
406 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
407 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
408 3QRG 1 L Fab light chain 9606
409 3QRG 2 H Fab heavy chain Fd fragment 9606
410 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
411 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
412 5M6A 1 A, B, C, D Bence-Jones light chain 9606
413 4LLY 2 B, D light chain Clambda 9606
414 4LGR 2 B Camelid nanobody (VHH3) 30538
415 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
416 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
417 5EZI 1 H Fab c12 heavy chain 9606
418 5EZI 2 L Fab c12 Light chain 9606
419 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
420 4K23 1 H anti-uPAR antibody, heavy chain 10090
421 4K23 2 L anti-uPAR antibody, light chain 10090
422 5J57 2 B VHH single chain antibody V5E1 30538
423 3NCJ 1 L Fab15 Mut8 light chain 9606
424 3NCJ 2 H Fab15 Mut8 heavy chain 9606
425 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
426 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
427 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
428 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
429 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
430 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
431 5W05 1 L M59 FAB LIGHT CHAIN 10090
432 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
433 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
434 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
435 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
436 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
437 5OMM 2 C Nanobody (VHH) Nano-14 30538
438 5E03 1 A mouse CTLA-4 nanobody 10090
439 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
440 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
441 4M61 1 A, C Fab A52 light chain 10090
442 4M61 2 B, D Fab A52 heavy chain 10090
443 5YE3 1 B 2A7D9 VH CH1 chain 10090
444 5YE3 2 A 2A7D9 L chain 10090
445 5LZ0 1 A, B PorM nanobody 9844
446 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
447 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
448 1UM5 1 L Antibody 21H3 L chain 10090
449 1UM5 2 H Antibody 21H3 H chain 10090
450 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
451 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
452 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
453 4NWT 1 L APE1531 Ab Fab light chain 9606
454 4NWT 2 H APE1531 Ab Fab heavy chain 9606
455 6DBE 1 A, B nanobody VHH R303 9844
456 3WHX 1 A mAb Fab H fragment 10090
457 3WHX 2 B mAb Fab L fragment 10090
458 3NA9 1 L Fab15 light chain 9606
459 3NA9 2 H Fab15 heavy chain 9606
460 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
461 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
462 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
463 6FUO 2 B Human F11 T-Cell Receptor 9606
464 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
465 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
466 4LRI 1 A, B MSL-109 Light Chain 9606
467 4LRI 2 C, P MSL-109 Heavy Chain 9606
468 2XXC 1 B CAMELID VHH 9 30538
469 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
470 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
471 4JN2 1 A, L anti dabigatran Fab 10090
472 4JN2 2 B, H anti dabigatran Fab 10090
473 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
474 4XBE 2 H 4E10 Fab heavy chain 9606
475 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
476 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
477 6BE2 1 H Fab (F598) Heavy Chain 9606
478 6BE2 2 L Fab (F598) Light Chain 9606
479 3QYC 1 A, B VH domain of IgG molecule 9606
480 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
481 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
482 4JFZ 1 L Fab light chain 9606
483 4JFZ 2 H Fab heavy chain 9606
484 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
485 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
486 5VAK 2 B Nb914 Nanobody 9844
487 3WIF 1 A mAb Fab H fragment 10090
488 3WIF 2 B mAb Fab L fragment 10090
489 5U6A 1 A Light Chain 9606
490 5U6A 2 B Heavy Chain 9606
491 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
492 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
493 3MBX 1 L X836 LIGHT CHAIN 10090
494 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
495 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
496 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
497 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
498 2XXM 2 B CAMELID VHH 9 30538
499 6APC 1 H Epididymis luminal protein 214 9606
500 6APC 2 L IGL@ protein 9606
501 6BJ8 3 D TCR 55 alpha chain 9606
502 6BJ8 4 H TCR 55 beta chain 9606
503 5IR3 1 A Ig lambda chain V-VI region AR 9606
504 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
505 4HHA 1 A Fab KE5 Fab fragment KE5 9606
506 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
507 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
508 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
509 4RGO 2 H 14G8 heavy chain Fab 10090
510 4RGO 3 L 14G8 light chain Fab 10090
511 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
512 5GRY 1 A, G diabody 9606
513 5UEK 2 H Fab 12E Heavy Chain 9606
514 5UEK 3 L Fab 12E Light Chain 9606
515 3NAA 1 L Fab15 Mut5 light chain 9606
516 3NAA 2 H Fab15 Mut5 heavy chain 9606
517 6DBD 1 A, B, C, D nanobody VHH R326 9844
518 1Q0X 1 L Fab 9B1, light chain 10090
519 1Q0X 2 H Fab 9B1, heavy chain 10090
520 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
521 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
522 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
523 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
524 5JDS 1 B Nanobody 9835
525 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
526 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
527 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
528 5IK3 2 B, D 1E03 Fab fragment light chain 9606
529 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
530 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
531 5XLI 1 a, b FabL 10090
532 5XLI 2 c, d FabH 10090
533 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
534 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
535 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
536 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
537 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
538 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
539 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
540 4WUK 1 H CH65 heavy chain 9606
541 4WUK 2 L CH65 light chain 9606
542 5L8L 2 B New antigen receptor variable domain 168098
543 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
544 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
545 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
546 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
547 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
548 5JOP 1 D, L Fab 14.22 light chain 10090
549 5JOP 2 E, H Fab14.22 heavy chain 10090
550 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
551 4HPO 1 H CH58 Fab heavy chain 9606
552 4HPO 2 L CH58 Fab light chain 9606
553 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
554 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
555 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
556 5UKN 2 L DH522UCA Fab fragment light chain 9544
557 4AIZ 1 A, C, D V2-17 PROTEIN 9606
558 4AIZ 2 B V2-17 PROTEIN 9606
559 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
560 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
561 5L21 2 B VHH-C2 30538
562 5IT2 1 H heavy chain 9606
563 5IT2 2 L light chain 9606
564 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
565 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
566 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
567 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
568 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
569 2W59 1 A, B IGY FCU3-4 9031
570 5FWO 1 A NANOBODY 9844
571 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
572 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
573 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
574 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
575 4L1H 1 A Ig kappa chain V-I region Rei 9606
576 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
577 5MO3 3 L Fab of monoclonal antibody, light chain 10090
578 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
579 5GZ0 1 A, C FM329 light chain 1383439
580 5GZ0 2 B, D FM329 heavy chain 1383439
581 6DW2 1 A 6078 Fab light chain 9606
582 6DW2 2 B 6078 Fab heavy chain 9606
583 3B9V 1 A, B, C, D heavy chain variable domain 9606
584 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
585 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
586 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
587 6BQB 1 L MGG4 Fab light chain 9606
588 6BQB 2 H MGG4 Fab heavy chain 9606
589 4PUB 1 H DX-2930 HEAVY CHAIN 9606
590 4PUB 2 L DX-2930 LIGHT CHAIN 9606
591 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
592 6B14 2 L Light chain of Fab BL3-6S97N 10090
593 5N88 1 A, H VH59 antibody 9606
594 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
595 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
596 5TEZ 4 I TCR F50 alpha chain 9606
597 5TEZ 5 J TCR F50 beta chain 9606
598 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
599 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
600 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
601 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
602 5GS3 1 A, H diabody protein 9606
603 3BD3 1 A, B catalytic antibody 10090
604 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
605 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
606 2OTU 1 A, C, E, G Fv light chain variable domain 10090
607 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
608 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
609 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
610 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
611 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
612 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
613 5VKD 2 H Fab Heavy Chain 9606
614 5VKD 3 L Fab light chain 9606
615 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
616 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
617 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
618 5XHG 1 A, C polypeptide(L) 10090
619 5XHG 2 B, D polypeptide(H) 10090
620 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
621 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
622 5L8J 2 B New antigen receptor variable domain 168098
623 3UYR 1 H antibody Fab heavy chain 10090
624 3UYR 2 L antibody Fab light chain 10090
625 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
626 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
627 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
628 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
629 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
630 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
631 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
632 3OAZ 2 K, L Fab 2G12, light chain 9606
633 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
634 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
635 1T6V 2 N, O novel antigen receptor 7801
636 1ZAN 1 L Fab AD11 Light Chain 10116
637 1ZAN 2 H Fab AD11 Heavy Chain 10116
638 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
639 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
640 6CJK 1 A, C Immunoglobulin Fab light chain 9986
641 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
642 4N0Y 1 H IGH526 Heavy Chain 9606
643 4N0Y 2 L IGH526 Light Chain 9606
644 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
645 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
646 5MTH 1 A, H antibody Fab heavy chain 10090
647 5MTH 2 B, L antibody Fab light chain 10090
648 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
649 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
650 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
651 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
652 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
653 1RZF 1 L Fab E51 light chain 9606
654 1RZF 2 H Fab E51 heavy chain 9606
655 4N1C 1 A, B immunoglobulin variable light chain domain 9606
656 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
657 4KTE 2 L GE148 Light Chain Fab 9544
658 5I8O 1 H HMM5 antibody heavy chain 9606
659 5I8O 2 L HMM5 antibody light chain 9606
660 4OUO 1 A anti Bla g 1 scFv 9031
661 4JG0 1 L Fab light chain 9606
662 4JG0 2 H Fab heavy chain 9606
663 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
664 4YGV 2 B, L aDabi-Fab2a light chain 9606
665 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
666 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
667 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
668 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
669 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
670 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
671 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
672 3EO0 1 A, C GC-1008 Fab Light Chain 10090
673 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
674 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
675 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
676 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
677 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
678 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
679 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
680 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
681 6FUR 2 B, D Human F11 T-Cell Receptor 9606
682 4POU 2 B VHH Antibody 9844
683 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
684 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
685 4FQI 3 H antibody CR9114 heavy chain Fab 9606
686 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
687 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
688 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
689 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
690 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
691 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
692 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
693 4JHA 2 L D25 light chain 9606
694 6B9Z 1 A Trastuzumab Fab light chain 10090
695 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
696 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
697 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
698 4PTT 1 A Antibody pn132p2C05, light chain 9606
699 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
700 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
701 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
702 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
703 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
704 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
705 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
706 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
707 2P42 2 B, D ANTIBODY CAB-RN05 9838
708 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
709 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
710 6CPH 1 D TCR alpha chain 9606
711 6CPH 2 E TCR beta chain 9606
712 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
713 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
714 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
715 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
716 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
717 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
718 4DGV 1 H HCV1 Heavy Chain Fab 9606
719 4DGV 2 L HCV1 Light Chain 9606
720 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
721 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
722 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
723 5TH2 1 A, C cetuximab Fab, light chain 10090
724 5TH2 2 B, D cetuximab Fab, heavy chain 10090
725 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
726 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
727 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
728 5I8K 1 L HHH1 Fab Light chain 9606
729 5I8K 2 H HHH1 Fab Heavy chain 9606
730 4QLR 1 A, B Llama nanobody n02 VH domain 9844
731 5J56 2 B VHH single chain antibody V1C7 30538
732 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
733 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
734 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
735 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
736 1YNL 1 L Ig gamma light chain 10090
737 1YNL 2 H Ig gamma heavy chain 10090
738 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
739 5EPM 2 B, F Antibody Fab fragment light chain 10090
740 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
741 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
742 5VH5 1 A Infliximab Fc 10090
743 3UMT 1 A scFv heavy chain and light chain 10090
744 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
745 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
746 4NUJ 1 A PGT152 light chain 9606
747 4NUJ 2 B PGT152 heavy chain 9606
748 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
749 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
750 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
751 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
752 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
753 3U2S 2 B, L PG9 light chain 9606
754 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
755 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
756 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
757 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
758 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
759 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
760 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
761 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
762 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
763 4NUG 1 L PGT151 light chain 9606
764 4NUG 2 H PGT151 heavy chain 9606
765 3IU4 1 H chP3 Fab heavy chain 10090
766 3IU4 2 L chP3 Fab light chain 10090
767 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
768 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
769 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
770 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
771 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
772 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
773 1P7K 1 A, L antibody light chain FAB 10090
774 1P7K 2 B, H antibody heavy chain FAB 10090
775 4NBX 2 B A20.1 VHH 9844
776 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
777 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
778 3RVV 2 C 4C1 - light chain 10090
779 3RVV 3 D 4C1 - heavy chain 10090
780 4HEP 2 G vHH17 domain 9844
781 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
782 3P0Y 2 H Fab DL11 heavy chain 9606
783 3P0Y 3 L Fab DL11 light chain 9606
784 4NPY 1 A, L germline PGT121 light chain Fab 9606
785 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
786 6ANA 2 H LL2 Fab Heavy Chain 10090
787 6ANA 3 L LL2 Fab Light Chain 10090
788 5IBU 1 B, L 6652 Light Chain 9606
789 5IBU 2 G, H 6652 Heavy Chain 9606
790 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
791 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
792 5VPL 2 C 4C1 - LIGHT CHAIN 10090
793 5VPL 3 D 4C1 - HEAVY CHAIN 10090
794 6AOD 1 A FXIa Antibody FAB Light Chain 9606
795 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
796 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
797 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
798 2YPV 2 H FAB 12C1 10090
799 2YPV 3 L FAB 12C1 10090
800 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
801 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
802 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
803 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
804 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
805 4JY5 1 L PGT122 light chain Fab 9606
806 4JY5 2 H PGT122 heavy chain Fab 9606
807 6ELE 1 A, H fAB heavy chain 9606
808 6ELE 2 B, L fAB light chain 9606
809 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
810 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
811 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
812 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
813 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
814 6B5R 1 H CIS42 Fab Heavy chain 9606
815 6B5R 2 L CIS42 Fab Light chain 9606
816 5IML 2 B Nanobody 9835
817 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
818 3NAC 1 L Fab15 Mut7 light chain 9606
819 3NAC 2 H Fab15 Mut7 heavy chain 9606
820 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
821 3A6C 2 H IG VH, anti-lysozyme 10090
822 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
823 2DQD 2 H Ig VH,anti-lysozyme 10090
824 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
825 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
826 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
827 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
828 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
829 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
830 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
831 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
832 1Q72 1 L Fab M82G2, Light chain 10090
833 1Q72 2 H Fab M82G2, Heavy chain 10090
834 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
835 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
836 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
837 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
838 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
839 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
840 4YHO 1 H aDabi-Fab3 heavy chain 9606
841 4YHO 2 L aDabi-Fab3 light chain 9606
842 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
843 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
844 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
845 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
846 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
847 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
848 4DGY 1 H HCV1 Heavy Chain Fab 9606
849 4DGY 2 L HCV1 Light Chain 9606
850 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
851 3A67 2 H IG VH, anti-lysozyme 10090
852 2APB 1 A T-cell receptor beta chain V 10116
853 2APX 1 A T cell receptor beta chain V 10116
854 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
855 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
856 6EH6 2 B Human T Cell Receptor BetaChain 9606
857 5EN2 1 A GD01 heavy chain 10090
858 5EN2 2 B GD01 light chain 10090
859 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
860 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
861 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
862 1J1X 2 H Ig VH,anti-lysozyme 10090
863 5L8K 2 B New antigen receptor variable domain 168098
864 5M2J 2 D Anti-(ED-B) scFV 9606
865 3MXW 2 L 5E1 light chain 9606
866 3MXW 3 H 5E1 heavy chain 9606
867 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
868 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
869 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
870 2DQC 2 H Ig VH,anti-lysozyme 10090
871 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
872 1J1O 2 H Ig VH,anti-lysozyme 10090
873 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
874 3EO9 1 L Efalizumab Fab fragment, light chain 9606
875 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
876 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
877 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
878 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
879 4M62 2 H, I GEP2 FV heavy chain 9606
880 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
881 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
882 5IVO 1 A BC2-nanobody 30538
883 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
884 1J1P 2 H Ig VH,anti-lysozyme 10090
885 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
886 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
887 4NBZ 2 B, D A26.8 VHH 9844
888 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
889 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
890 5WUV 1 L light chain 9606
891 5WUV 2 H heavy chain 9606
892 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
893 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
894 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
895 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
896 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
897 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
898 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
899 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
900 5AYU 2 H Ig VH,anti-lysozyme 10090
901 4JM4 1 H PGT 135 Heavy Chain Fab 9606
902 4JM4 2 L PGT 135 Light Chain Fab 9606
903 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
904 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
905 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
906 3A6B 2 H IG VH, anti-lysozyme 10090
907 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
908 2DQJ 2 H Ig VH,anti-lysozyme 10090
909 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
910 5YE4 2 B, D 1A9D7 L chain 10090
911 5F21 2 B nanobody MU375 9844
912 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
913 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
914 6B0G 1 C 1245 Antibody, Light Chain 9606
915 6B0G 2 D 1245 Antibody, Heavy Chain 9606
916 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
917 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
918 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
919 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
920 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant